Aurora Cannabis Inc.

Equities

ACB

CA05156X8504

Pharmaceuticals

Delayed Toronto S.E. 03:17:10 2024-03-28 pm EDT 5-day change 1st Jan Change
5.935 CAD -7.84% Intraday chart for Aurora Cannabis Inc. +14.35% -8.69%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Markets Take Breather After Last Week's Rally MT
US Equity Markets Close Mixed Friday as Dow Drops After Approaching 40,000 MT
Sector Update: Consumer Stocks Slipping Late Afternoon MT
Sector Update: Consumer MT
Top Midday Gainers MT
Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Cannabis Review Panel Recommends Changes to Excise Tax, Health Canada Regulations MT
Aurora Cannabis Shares Rise After Receipt of Australian Regulator's Certification MT
Toronto Stocks Higher; Boyd Group Says New Locations to Weigh on Earnings DJ
Aurora Cannabis Secures Australia's TGA GMP Certification MT
Aurora Cannabis Brief: Says Achieved Australia's TGA GMP Certification MT
Sector Update: Consumer Stocks Higher in Late Afternoon Trading MT
Wedbush on "The Clock is Ticking on Cannabis" MT
Cannabis Stocks Rise Following White House Roundtable on Marijuana Reform MT
Cannabis Stocks Rise Following White House Roundtable on Marijuana Reform MT
Aurora Cannabis Introduces Medical Cannabis Pastilles for Patient Relief in Australia MT
Aurora Cannabis Reports Operations Are Now Debt Free MT
Aurora Cannabis Brief: Says Completed Final Repayment of Convertible Senior Notes Representing Near $465 Million in Total Repayments Since 2021 MT
Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis; Down 1.8% MT
Aurora Cannabis Teams Up With Script Assist to Provide Access to UK Medical Cannabis MT
Aurora Cannabis Brief: Partnering with Script Assist to Provide Better Access to UK Medical Cannabis MT
Aurora Cannabis Names Simona King CFO; Completes Share Consolidation MT
Aurora Cannabis Announces CFO Transition, Completion of Share Consolidation MT
Chart Aurora Cannabis Inc.
More charts
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
6.44 CAD
Average target price
9.681 CAD
Spread / Average Target
+50.33%
Consensus
  1. Stock
  2. Equities
  3. Stock Aurora Cannabis Inc. - Toronto S.E.
  4. News Aurora Cannabis Inc.
  5. Cannabis Sector Brief: Gains Coming On Talk of New U.S. Legislation That Could Make It Easier For Pot Cos To Engage With Banks